4.7 Article

Two-year course of depressive and anxiety disorders: Results from the Netherlands Study of Depression and Anxiety (NESDA)

Journal

JOURNAL OF AFFECTIVE DISORDERS
Volume 133, Issue 1-2, Pages 76-85

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jad.2011.03.027

Keywords

Depression; Anxiety; Course; Comorbidity; Cohort study; Longitudinal

Funding

  1. Astra Zeneca
  2. Eli Lilly
  3. GlaxoSmithKline
  4. Wyeth
  5. Pfizer
  6. Servier
  7. Lundbeck
  8. Bristol-Meyers Squibb
  9. Organon
  10. Netherlands Organisation for Health Research and Development (Zon-Mw) [10-000-1002]
  11. VU University Medical Center
  12. GGZ inGeest
  13. Arkin
  14. Leiden University Medical Center
  15. GGZ Rivierduinen
  16. University Medical Center Groningen
  17. Lentis
  18. GGZ Friesland
  19. GGZ Drenthe
  20. Scientific Institute for Quality of Healthcare (IQ healthcare)
  21. Netherlands Institute for Health Services Research (NIVEL)
  22. Netherlands Institute of Mental Health and Addiction (Trimbos)

Ask authors/readers for more resources

Background: Whether course trajectories of depressive and anxiety disorders are different, remains an important question for clinical practice and informs future psychiatric nosology. This longitudinal study compares depressive and anxiety disorders in terms of diagnostic and symptom course trajectories, and examines clinical prognostic factors. Methods: Data are from 1209 depressive and/or anxiety patients residing in primary and specialized care settings, participating in the Netherlands Study of Depression and Anxiety. Diagnostic and Life Chart Interviews provided 2-year course information. Results: Course was more favorable for pure depression (n = 267, median episode duration = 6 months, 24.5% chronic) than for pure anxiety (n = 487, median duration = 16 months, 41.9% chronic). Worst course was observed in the comorbid depression-anxiety group (n = 455, median duration >24 months, 56.8% chronic). Independent predictors of poor diagnostic and symptom trajectory outcomes were severity and duration of index episode, comorbid depression-anxiety, earlier onset age and older age. With only these factors a reasonable discriminative ability (C-statistic 0.72-0.77) was reached in predicting 2-year prognosis. Limitation: Depression and anxiety cases concern prevalent - not incident - cases. This, however, reflects the actual patient population in primary and specialized care settings. Conclusions: Their differential course trajectory justifies separate consideration of pure depression, pure anxiety and comorbid anxiety-depression in clinical practice and psychiatric nosology. (C) 2011 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available